, Tracking Stock Market Picks
Enter Symbol:
Enzon Pharmaceuticals, Inc. (ENZN) [hlAlert]

down 89.88 %

Enzon Pharmaceuticals, Inc. (ENZN) rated Buy with price target $18 by C.K. Cooper

Posted on: Wednesday,  May 5, 2010  8:25 AM ET by C.K. Cooper

C.K. Cooper rated Buy Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) on 05/05/2010, when the stock price was $10.48. Since
then, Enzon Pharmaceuticals, Inc. has lost 89.89% as of 01/21/2016's recent price of $1.06.
If you would have followed this C.K. Cooper's recommendation on ENZN, you would have lost 89.88% of your investment in 2087 days.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases. Enzon's specialized sales force markets ABELCET, ONCASPAR, ADAGEN, and DEPOCYT in the United States. In addition, Enzon also receives royalties on sales of PEG-INTRON, marketed by Schering-Plough Corporation, and MACUGEN, marketed by OSI Pharmaceuticals and Pfizer Inc. Enzon's product-driven strategy includes an extensive drug development program that leverages its proprietary technologies, including a Customized Linker Technology PEGylation platform that utilizes customized linkers designed to release compounds at a controlled rate. Enzon also utilizes contract manufacturing opportunities to broaden its revenue base and enhance its organizational productivity. Enzon complements its internal research and development efforts with strategic initiatives.

C. K. Cooper & Company has for over a decade provided insightful research ideas and commentary. As the firm identifies focus industries it brings together an analytical team to provide unique vision and insight to select investment ideas. In addition, leveraging on the expertise of the firm, the Research Team can evaluate opportunities against a wide database of industry and competitive trends.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/5/2010 8:25 AM Buy
10.48 18.00
as of 12/31/2010
1 Week down  -7.29 %
1 Month up  4.04 %
3 Months up  2.93 %
1 YTD up  10.40 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy